Pancreatic cancer, the ultimate master of disguise, often sneaks in without a grand entrance—until it is already made itself ...
“No signs of cancer.” While pancreatic cancer remains ... The family has a genetic mutation that makes it more likely they’d ...
Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announced positive results from the VERIFI study, the second clinical validation study of its next-generation ...
In the seriously great news department, pancreatic cancer is expected to pass colorectal cancer as the second biggest cause ...
A definition of patient populations for second-line studies must be established ... after the failure of first-line gemcitabine in pancreatic cancer to date. Future studies should test the ...
Researchers at the Garvan Institute of Medical Research have uncovered how pancreatic cancer hijacks a crucial metabolic ...
The FDA has granted orphan drug designation to PEP-010 for pancreatic cancer, advancing its development as a potential novel ...
“No signs of cancer ... has a genetic mutation that makes it more likely they’d have pancreatic cancer. “I have a second chance in life, and I do my best to make the best of it, ...